Hasil Pencarian  ::  Simpan CSV :: Kembali

Hasil Pencarian

Ditemukan 150570 dokumen yang sesuai dengan query
cover
Caesar Nurfiansyah
Sensitivitas dan Spesifisitas AFP dan LDH sebagai Penanda Tumor pada Neoplasma Padat Ovarium = Sensitivity adn Specificity of AFP and LDH as Tumor Marker of Solid Ovarian Neoplasm.
"Metode : Penelitian ini merupakan penelitian uji diagnostik dengan menggunakan metode potong lintang. Pengambilan sampel dilakukan secara konsekutif. Penelitian dilakukan di Poliklinik Obstetri dan Ginekologi RSCM Jakarta pada 31 Januari 2015 hingga 31 Januari 2020. Sebanyak 183 pasien wanita dengan kecurigaan neoplasma ovarium padat diikutsertakan dalam penelitian. Pasien dengan penyakit sistemik lainnya atau mengalami kehamilan dieksklusi dari penetlitian. Dilakukan uji kesesuaian dengan menggunakan uji Kappa. Didapatkan sensitivitas dan spesifisitas dari masing-masing penanda tumor
Hasil : AFP memiliki sensitivitas 1,92% dan spesifisitas 77,1% sebagai penanda disgerminoma. LDH memiliki sensitivitas 55,67% dan spesifisitas 65,65% sebagai penanda disgerminoma.. AFP memiliki sensitivitas 30,43% dan spesifisitas 85% sebagai penanda teratoma. LDH memiliki sensitivitas 30,43% dan spesifisitas 58,13% sebagai penanda teratoma . AFP memiliki sensitivitas 100% dan spesifisitas 88,89% sebagai penanda Yolk sac tumor. LDH memiliki sensitivitas 41,67% dan spesifisitas 59,65% sebagai penanda Yolk sac tumor. Kombinasi AFP dan LDH memiliki sensitivitas 100% dan spesifisitas 50,29% sebagai penanda Yolk sac tumor. Kombinasi tumor marker AFP dan LDH memiliki nilai sensitivitas yang lebih tinggi namun tidak memiliki akurasi yang lebih baik dibandingkan pemeriksaan menggunakan AFP atau LDH saja.
Kesimpulan : AFP dan LDH merupakan penanda tumor yang dapat digunakan untuk deteksi dini maupun skrining pada kasus neoplasma padat ovarium.
Background: Ovarian neoplasms are the most common malignancy experienced by women in Indonesia. Solid ovarian neoplasm is a form of ovarian neopalsma that has a low survival rate due to late diagnosis. Early detection using tumor markers is one of the focuses of researches on ovarian neoplasms, one of which includes AFP and LDH.
Objective : To determine the sensitivity and specificity of AFP, LDH, and the combination of the two tumor markers.
Method : This research is a diagnostic test using cross sectional method. Sampling is done consecutively. The study was conducted at the Obstetrics and Gynecology Clinic of RSCM Jakarta from 31 January 2015 to 31 January 2020. A total of 182 female patients with suspicion of solid ovarian neoplasms were included in the study. Patients with other systemic diseases or pregnant were excluded from research. Conformity test was performed using the Kappa test. Sensitivity and specificity of each tumor marker was obtained
Result : AFP has a sensitivity of 1.92% and specificity of 77.1% as a marker of dysgerminoma. LDH has a sensitivity of 55.67% and a specificity of 65.65% as a marker of dysgerminoma. AFP has a sensitivity of 30.43% and a specificity of 85% as a marker of teratoma. LDH has a sensitivity of 30.43% and specificity 58.13% as a marker of teratomas. AFP has 100% sensitivity and 88.89% specificity as a marker of Yolk sac tumor. LDH has a sensitivity of 41.67% and specificity 59.65% as a marker of Yolk sac tumor. The combination of AFP and LDH has a sensitivity of 100% and a specificity of 50.29% as a marker of Yolk sac tumor. The combination of AFP and LDH marker tumors has a higher sensitivity value but does not have better accuracy than examinations using AFP or LDH alone"
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2020
T-Pdf
UI - Tesis Membership  Universitas Indonesia Library
cover
Yayi Dwina Bilianti Susanto
Perubahan arsitektur dan sitomorfologi sel pada cairan peritoneum sebagai penanda keganasan neoplasma epitelial ovarium = Architectural and cytomorphology changes in peritoneal fluid as a sign of malignancy in ovarian epithelial neoplasm / Yayi Dwina Bilianti Susanto
"[ABSTRAK
Latar belakang: Interpretasi cairan peritoneum yang tepat secara sitopatologi sangat
mempengaruhi tatalaksana dan prognosis pasien, padahal pemeriksaan sitopatologi cairan
peritoneum masih memiliki nilai negatif palsu dan positif palsu yang cukup tinggi, dan
hingga saat ini penelitian tentang arsitektur sitopatologi maupun penanda sitomorfologi yang
mengarahkan pada adanya sel neoplasma di cairan peritoneum masih menunjukkan hasil
yang beragam.
Bahan dan cara kerja: Penelitian potong lintang dengan data sekunder berupa slaid
dan formulir sediaan sitopatologi cairan peritoneum yang memiliki data berpasangan dengan
diagnosis histopatologi. Diagnosis klinis berupa neoplasma epitelial ovarium. Slaid dan
formulir diambil dari arsip Departemen Patologi Anatomik FKUI/RSCM tahun 2011 ? 2012,
dilakukan pembacaan ulang semua slaid sitopatologi dengan diagnosis akhir dikategorikan
sebagai positif atau negatif, peneliti membaca pula sediaan histopatologi untuk mengetahui
morfologi sel pada lesi, kemudiaan dilakukan penilaian terhadap arsitektur sitopatologi
berupa: selularitas, sel berkelompok, struktur papiler, intercelular windows, group contours,
jisim psamoma, dan penanda sitomorfologi berupa: atipia inti, inti bertumpuk, anak inti,
rasio inti:sitoplasma, ukuran inti, dan ukuran sel.
Hasil penelitian: Sampel penelitian sejumlah 47 sediaan sitopatologi dengan
diagnosis sitopatologi akhir 34 kasus (72.3%) negatif, 13 kasus (27.7%) positif. Terdapat
perbedaan bermakna arsitektur sitopatologi berupa: selularitas (p = 0.017), sel berkelompok
(p = 0.001), intercellular windows (p = 0.00), group contours (p = 0.00), dan gambaran
sitomorfologi berupa: atipia inti (p = 0.00), inti bertumpuk (p = 0.001), anak inti (p = 0.001),
rasio inti:sitoplasma (p = 0.00), ukuran inti (p = 0.00), ukuran sel (p = 0.00) antara cairan
peritoneum positif dan negatif. Melalui uji multivariat didapatkan penanda yang paling
berpengaruh terhadap diagnosis sitopatologi positif atau negatif yaitu: intercellular windows,
atipia inti, dan selularitas.
Kesimpulan: Terdapat tiga penanda yang paling berpengaruh terhadap diagnosis
positif ditemukannya sel neoplasma ganas dalam cairan peritoneum pada kasus dengan lesi
ovarium, secara berturut - turut yaitu: tidak ditemukannya intercellular windows pada
kelompokan sel, sel memiliki atipia inti sedang hingga berat, dan selularitas lebih dari 20
kelompok dari keseluruhan sediaan apus.
ABSTRACT
Background : Peritoneal fluid cytopathology interpretation profoundly influences patients
management and prognosis, however this practice still has high false positive and false
negative value, and until now research concerning the architectural and cytomorphology
features for detecting malignant cells in peritoneal fluid still has various result.
Materials and Methods : Cross sectional study using secondary data of peritoneal fluid
cytopathology and histopathology slides and form, from patients with clinical diagnosis of
ovarian epithelial neoplasm. The data was taken from the archive of Anatomical Pathology
Department Cipto Mangunkusumo Hospital 2011 ? 2012. The researchers examined the
cytopathology slides and also examined the histopatology slide for morphology comparison,
and then make a final cytopathological diagnosis of positive peritoneal fluid containing
neoplastic cells or negative. Architectural features including: cellularity, cells grouping,
papillary structure, intercellular windows, group contours, psamoma bodies, and
cytomorphology features including: nuclear atypia, overlapping nuclei, nucleoli, nuclei :
cytoplasm ratio, the dimension of the nuclei and cells were also examined.
Result : There were 47 samples with final cytopathology diagnosis: 34 cases (72.3%)
negative for neoplastic cells in the peritoneal fluid and 13 cases (27.7%) positive. There were
significant differences in cytopathology architectural including cellularity (p = 0.017), cells
grouping (p = 0.001), intercellular windows (p = 0.00), group contours (p = 0.00) and
cytomorphology features including nuclear atypia (p = 0.00), overlapping nuclei (p = 0.001),
nucleoli (p =0.001), nuclei : cytoplasm ratio (p = 0.00), the dimension of nuclei (p = 0.00),
the dimension of cell (p = 0.00) between the positive and negative peritoneal fluid
cytopathology. Using multivariate analysis there were 3 cytological features that have the
strongest association with positive or negative peritoneal cytopathology diagnosis, they were:
intercellular windows, nuclear atypia, and cellularity.
Conclusion: In peritoneal fluid cytopathology for examining ovarian lesion there were 3
cytological features that have the strongest association with finding neoplastic cells in
peritoneal fluid, they were: the absent of intercellular windows, moderate to severe
cytological atypia, and cellularity more than 20 groups in all smear preparation, Background : Peritoneal fluid cytopathology interpretation profoundly influences patients
management and prognosis, however this practice still has high false positive and false
negative value, and until now research concerning the architectural and cytomorphology
features for detecting malignant cells in peritoneal fluid still has various result.
Materials and Methods : Cross sectional study using secondary data of peritoneal fluid
cytopathology and histopathology slides and form, from patients with clinical diagnosis of
ovarian epithelial neoplasm. The data was taken from the archive of Anatomical Pathology
Department Cipto Mangunkusumo Hospital 2011 – 2012. The researchers examined the
cytopathology slides and also examined the histopatology slide for morphology comparison,
and then make a final cytopathological diagnosis of positive peritoneal fluid containing
neoplastic cells or negative. Architectural features including: cellularity, cells grouping,
papillary structure, intercellular windows, group contours, psamoma bodies, and
cytomorphology features including: nuclear atypia, overlapping nuclei, nucleoli, nuclei :
cytoplasm ratio, the dimension of the nuclei and cells were also examined.
Result : There were 47 samples with final cytopathology diagnosis: 34 cases (72.3%)
negative for neoplastic cells in the peritoneal fluid and 13 cases (27.7%) positive. There were
significant differences in cytopathology architectural including cellularity (p = 0.017), cells
grouping (p = 0.001), intercellular windows (p = 0.00), group contours (p = 0.00) and
cytomorphology features including nuclear atypia (p = 0.00), overlapping nuclei (p = 0.001),
nucleoli (p =0.001), nuclei : cytoplasm ratio (p = 0.00), the dimension of nuclei (p = 0.00),
the dimension of cell (p = 0.00) between the positive and negative peritoneal fluid
cytopathology. Using multivariate analysis there were 3 cytological features that have the
strongest association with positive or negative peritoneal cytopathology diagnosis, they were:
intercellular windows, nuclear atypia, and cellularity.
Conclusion: In peritoneal fluid cytopathology for examining ovarian lesion there were 3
cytological features that have the strongest association with finding neoplastic cells in
peritoneal fluid, they were: the absent of intercellular windows, moderate to severe
cytological atypia, and cellularity more than 20 groups in all smear preparation]"
2015
T-Pdf
UI - Tesis Membership  Universitas Indonesia Library
cover
Florinda Ilona
Ekspresi glucose transporter (GLUT)-1 sebagai penanda imunodiagnostik pada tumor ovarium serosum borderline dan ganas = Glucose transporter (GLUT)-1 expression as immunodiagnostic marker in serous borderline and malignant tumours of the ovary
"Latar belakang: Frekuensi tumor ovarium serosum ganas menempati urutan tertinggi dari seluruh keganasan ovarium di dunia barat 80-85 , sesuai dengan arsip Departemen Patologi Anatomik Fakultas Kedokteran Universitas Indonesia FKUI /Rumah Sakit Cipto Mangunkusumo RSCM selama 10 tahun 2004-2013 , sebanyak 200 kasus 21,4 dari seluruh keganasan ovarium. GLUT-1 dapat digunakan sebagai penanda perangai biologik tumor ovarium serosum. Tujuan penelitian ini membandingkan ekspresi GLUT-1 pada tumor ovarium serosum borderline dan ganas serta faktor risiko.Metode: Penelitian ini menggunakan metode potong lintang. Sampel terdiri atas 17 kasus untuk masing masing kelompok tumor ovarium serosum borderline dan ganas. Dilakukan pulasan GLUT-1 dengan penilaian berdasarkan intensitas dan jumlah sitoplasma dan/atau membran sel yang terpulas. Dilakukan penghitungan histoscore dan persentase setiap kasus dan dinilai ekspresi GLUT-1 berdasarkan titik potong kemudian dikelompokkan menjadi ekspresi rendah dan tinggi.Hasil: Pulasan GLUT-1 ekspresi rendah sama banyak dengan ekspresi tinggi. Sebagian besar kelompok tumor ovarium serosum borderline menunjukkan ekspresi rendah. Kelompok tumor ovarium serosum ganas sebagian besar menunjukkan ekspresi tinggi. Perbedaan ekspresi GLUT-1 antara tumor ovarium serosum borderline dan ganas, secara statistik bermakna p
Background The frequency of serous malignant tumors of ovary occupies the highest order of all ovarian malignancies in the western world 80 85 , in accordance with Department of Anatomical Pathology, Faculty of Medicine University of Indonesia Cipto Mangunkusumo hospital datas, for 10 years 2004 2013 , as many as 200 cases 21.4 of all ovarian malignancies. GLUT 1 can be used as a marker in differentiating biological behaviour of serous ovarian tumor. The aim of the study was to compare expression of GLUT 1 in serous borderline and malignant tumours of the ovary. Methods This was cross sectional study. Sample consists of 17 cases for each group, serous borderline and malignant tumor of ovary, stained with GLUT 1 antibody. Quantification was based on the intensity and distribution of cytoplasm and or cell membrane. The appraisal was done with estimating histoscore and percentage of each case. Calculation result was assessed by GLUT 1 expression, based on the point of intersection and then grouped into low and high expression. Result The GLUT 1 low expression results are equal with high expression. Low grade expression found in majority cases of serous borderline ovarian tumors group. Groups of serous malignant ovarian tumors largely exhibit high expression. These differences in Glut 1 expression among the borderline and malignant cases, are statistically significant p"
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2018
T-pdf
UI - Tesis Membership  Universitas Indonesia Library
cover
Florinda Ilona
Ekspresi glucose transporter (GLUT)-1 sebagai penanda imunodiagnostik pada tumor ovarium serosum borderline dan ganas = Glucose transporter (GLUT)-1 expression as immunodiagnostic marker in serous borderline and malignant tumours of the ovary.
"ABSTRAK
Latar belakang: Frekuensi tumor ovarium serosum ganas menempati urutan tertinggi dari seluruh keganasan ovarium di dunia barat 80-85 , sesuai dengan arsip Departemen Patologi Anatomik Fakultas Kedokteran Universitas Indonesia FKUI /Rumah Sakit Cipto Mangunkusumo RSCM selama 10 tahun 2004-2013 , sebanyak 200 kasus 21,4 dari seluruh keganasan ovarium. GLUT-1 dapat digunakan sebagai penanda perangai biologik tumor ovarium serosum. Tujuan penelitian ini membandingkan ekspresi GLUT-1 pada tumor ovarium serosum borderline dan ganas serta faktor risiko.Metode: Penelitian ini menggunakan metode potong lintang. Sampel terdiri atas 17 kasus untuk masing masing kelompok tumor ovarium serosum borderline dan ganas. Dilakukan pulasan GLUT-1 dengan penilaian berdasarkan intensitas dan jumlah sitoplasma dan/atau membran sel yang terpulas. Dilakukan penghitungan histoscore dan persentase setiap kasus dan dinilai ekspresi GLUT-1 berdasarkan titik potong kemudian dikelompokkan menjadi ekspresi rendah dan tinggi.Hasil: Pulasan GLUT-1 ekspresi rendah sama banyak dengan ekspresi tinggi. Sebagian besar kelompok tumor ovarium serosum borderline menunjukkan ekspresi rendah. Kelompok tumor ovarium serosum ganas sebagian besar menunjukkan ekspresi tinggi. Perbedaan ekspresi GLUT-1 antara tumor ovarium serosum borderline dan ganas, secara statistik bermakna p ABSTRACT
Background : The frequency of serous malignant tumors of ovary occupies the highest order of all ovarian malignancies in the western world 80-85 , in accordance with Department of Anatomical Pathology, Faculty of Medicine University of Indonesia / Cipto Mangunkusumo hospital datas, for 10 years 2004-2013 , as many as 200 cases 21.4 of all ovarian malignancies. GLUT-1 can be used as a marker in differentiating biological behaviour of serous ovarian tumor. The aim of the study was to compare expression of GLUT-1 in serous borderline and malignant tumours of the ovary. Methods : This was cross-sectional study. Sample consists of 17 cases for each group, serous borderline and malignant tumor of ovary, stained with GLUT-1 antibody. Quantification was based on the intensity and distribution of cytoplasm and/or cell membrane. The appraisal was done with estimating histoscore and percentage of each case. Calculation result was assessed by GLUT-1 expression, based on the point of intersection and then grouped into low and high expression.Result : The GLUT-1 low expression results are equal with high expression. Low grade expression found in majority cases of serous borderline ovarian tumors group. Groups of serous malignant ovarian tumors largely exhibit high expression. These differences in Glut-1 expression among the borderline and malignant cases, are statistically significant p"
2018
T-Pdf
UI - Tesis Membership  Universitas Indonesia Library
cover
Shirley Mansur
Perbandingan sensitivitas dan spesifisitas dari Skor Gatot, modifikasi Skor Gatot dan Risk Malignancy Index dalam memprediksi Keganasan Ovarium = Comparison of sensitivity and specificity of Gatot Score and its modification also Risk Malignancy Index in predicting Ovarian Malignancies / Shirley Mansur
"Tujuan : Penelitian ini ditujukan untuk mengevaluasi sensitivitas dan spesifisitas dari beberapa metode penapisan keganasan pada tumor ovarium jenis epitelial dengan membandingkan Skor Gatot dan Risk Malignancy Index, serta mengajukan modifikasi Skor Gatot.
Metode : Empat ratus satu pasien dengan kecurigaan keganasan ovarium tipe epithelial dimasukkan sebagai subjek penelitian, dilakukan prosedur anamnesis, pemeriksaan fisik, laboratoris dan ultrasonografi. Dari data tersebut, diambil variabel-variabel yang sesuai dengan Skor Gatot dan Risk Malignancy Index. Dilakukan analisa statistik berupa perhitungan sensitivitas dan spesifisitas serta ROC dan titik potong optimal.
Hasil : Dari 401 subjek penelitian, didapatkan bahwa Skor Gatot memiliki sensitivitas 73.7% dan spesifitas 45.6% (p = 0.000; LR 28.830) sedangkan RMI memiliki nilai sensitivitas 72.4%, spesifisitas 35.94% (p = 0.02, LR 9.588) untuk RMI 1 dan nilai sensitivitas 76%, spesifisitas 30.9% (p = 0.05; LR 7.984) untuk RMI 2. Dilakukan modifikasi pada Skor Gatot dengan pembobotan ulang pada tiap variabel, didapatkan hasil Modifikasi Skor Gatot 1 memiliki titik potong pada nilai 28.5 dengan sensitivitas sebesar 60.4% dan spesifisitas sebesar 61.4% (p= 0.000, LR 44.228) dan Modifikasi Skor Gatot 2 memiliki nilai potong pada titik 5.75 dengan kisaran nilai sensitivitas 49.3 – 69.6% dan sensitivitas 51.6-65.2% ( p = 0.000; LR 36.806).
Kesimpulan : Skor Gatot dan RMI memberikan hasil yang kurang memuaskan dalam melakukan prediksi keganasan ovarium. Dengan melakukan pembobotan ulang pada tiap variabel pada Skor Gatot, sensitivitas dan, terutama, spesifisitas dapat ditingkatkan dalam mendeteksi adanya keganasan ovarium tipe epitelial. Hal ini ditujukan agar dapat meningkatkan prediksi keganasan pada pasien dalam usia reproduksi.
Objective : The study was designed to evaluate the sensitivity and specificity of several methods in detecting ovarian epithelial malignancy by comparing Gatot Score and Risk Malignancy Index, and also proposing the modification of Gatot Score.
Method : Four hundred and one subjects with suspected epithelial ovarian malignancy entered the study and performed anamnesis, physical examinations, laboratories studies and ultrasonography. From the data, we took the variables according to Gatot Score and Risk Malignancy Index. We performed statistic analysis in term of sensitivity, specificity, ROC and optimal cut-off-point.
Results : From 401 observation subjects, revealed that Gatot Score possess the sensitivity of 73.7% and specificity of 45.6% (p = 0.000; LR 28.830), while RMI possess the sensitivity of 72.4% and specificity of 35.94% (p = 0.02, LR 9.588) for RMI 1, and the sensitivity of 76% and specificity of 30.9% (p = 0.05; LR 7.984) for RMI 2. Modification to Gatot Score was performed by re-weighting to its all variables, which resulted in Gatot Score Modification 1 with cut-off point of 28.5, sensitivity of 60.4% and specificity of 35.94% (p= 0.000, LR 44.228) and Gatot Score Modification 2 with cut-off point of 5.75, sensitivity range between 49.3 – 69.6% and specificity range between 51.6-65.2% ( p = 0.000; LR 36.806).
Summary : Both Gatot Score and RMI resulted in unsatisfactory output in predicting the malignancy of ovary. By reassigning the weighting of all variables in Gatot Score, especially the specificity was improved in detecting the malignancy of epithelial type ovary. This measure was directed for patients in reproductive ages, thus increasing the possibility of true malignancy."
Fakultas Kedokteran Universitas Indonesia, 2012
T-Pdf
UI - Tesis Membership  Universitas Indonesia Library
cover
Inadia Putri Chairista
Sensitivitas dan Spesifisitas Kriteria Klinis ABCDE Sebagai Skrining Karsinoma Sel Basal Berpigmen pada Populasi Kulit Berwarna = Sensitivity and Specificity of ABCDE Clinical Criteria for the Screening of Pigmented Basal Cell Carcinoma in Skin of Color
"Latar Belakang: Skrining kanker kulit dilakukan sebagai salah satu upaya dalam mengurangi morbiditas dan mortalitas yang ditimbulkan akibat kanker kulit. Karsinoma sel basal (KSB) merupakan salah satu kanker kulit yang paling sering ditemukan. KSB berpigmen seringkali menunjukkan fitur klinis yang menyerupai melanoma, sehingga kriteria klinis ABCDE diduga dapat menjadi salah satu pilihan dalam membantu penegakan diagnosis.
Tujuan: Mengevaluasi kriteria klinis ABCDE sebagai alat bantu skrining KSB berpigmen dibandingkan dengan baku emas histopatologik.
Metode: Penelitian potong lintang analitik ini dilakukan pada bulan Januari sampai dengan Juni 2023 di Rumah Sakit Umum Pusat Nasional dr. Cipto Mangunkusumo (RSUPNCM). Pasien dengan lesi tumor kulit berpigmen dari tahun 2017 sampai dengan 2022 yang mempunyai data klinis, histopatologis, dan foto dokumentasi yang lengkap direkrut ke dalam penelitian secara konsekutif. Kriteria eksklusi mencakup lesi berukuran lebih dari 2 cm, ras kulit putih (tipe kulit Fitzpatrick 1-3), serta hasil pembacaan histopatologis lesi tumor sesuai dengan penyakit prakanker dan kanker kulit lainnya. Data diolah secara statistik menggunakan perangkat lunak Stata versi 16 (StataCorpTM) dan Medcalc diagnostic evaluation test calculator.
Hasil: Sebanyak 84 pasien direkrut ke dalam penelitian dengan total 95 lesi yang mencakup 61 lesi KSB dan 34 lesi non-KSB. Median usia subjek KSB lebih tua dibandingkan dengan usia subjek non-KSB (p<0,001). Median ukuran lesi KSB lebih besar dibandingkan dengan ukuran lesi non-KSB (p<0,001). Lesi pada subjek KSB lebih banyak di wajah dibandingkan dengan subjek non-KSB (p=0,005). Proporsi kepositivan KSB berdasarkan kriteria klinis ABCDE adalah 87,5%. Kriteria klinis ABCDE menunjukkan sensitivitas 57,4% (interval kepercayaan [IK] 95% 44,0%–70,0%); spesifisitas 85,3% (IK 95% 68,9%–95,0%); nilai duga positif 87,5% (IK 95% 75,2%–94,2%); nilai duga negatif 52,7% (IK 95% 44,7%–60,6%); dan akurasi 67,4% (IK 95% 57,0%–76,6%) dalam mendiagnosis KSB berpigmen.
Kesimpulan: Kriteria klinis ABCDE secara lengkap mempunyai nilai diagnostik yang kurang baik sebagai alat bantu skrining KSB berpigmen.
Background: Skin cancer screening is performed as an effort to reduce the morbidity and mortality caused by skin cancer. Basal cell carcinoma (BCC) is one of the most common skin cancers. Pigmented BCC often shows clinical features resembling melanoma, so that ABCDE clinical criteria are thought to be a potential modality to help establishing the diagnosis of pigmented BCC.
Objective: To evaluate the ABCDE clinical criteria for the screening of pigmented BCC compared to histopathological examination as the gold standard examination.
Method: This analytical cross-sectional study was performed from January to June 2023 in dr. Cipto Mangunkusumo National Central General Hospital (RSUPNCM). Subjects with pigmented skin lesions visiting RSUPNCM from 2017 to 2022 whose clinical data, histopathological data, and photographs were documented completely were recruited to the study consecutively. Exclusion criteria included lesion’s size more than 2 cm, light skin (Fitzpatrick skin type 1-3), and histopathological diagnosis in line with precancerous lesion or other skin cancer. Data were analyzed with Stata software version 16 (StataCorpTM) and Medcalc diagnostic evaluation test calculator.
Results: A total of 84 subjects were recruited to the study with a total of 95 lesions consisting of 61 BCC lesions and 35 non-BCC lesions. Median age of the BCC subjects was older than that of non-BCC subjects (p<0.001). Median lesion’s size of the BCC lesions was larger than that of non-BCC lesions (p<0.001). The lesion location in BCC subjects was significantly prevalent on the face (p=0.005). The proportion of BCC positivity based on ABCDE clinical criteria was 87.5%. ABCDE criteria had sensitivity of 57.4% (95% Confidence Interval [CI] 44.0%–70.0%); specificity of 85.3% (95% CI 68.9%–95.0%); PPV of 87.5% (95% CI 75.2%–94.2%); NPV of 52.7% (95% CI 44.7%–60.6%); and accuracy of 67.4% (95% CI 57.0%–76.6%) in diagnosing pigmented BCC.
Conclusion: Fulfilling all ABCDE clinical criteria had poor diagnostic value for the screening of pigmented BCC."
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2023
SP-pdf
UI - Tugas Akhir  Universitas Indonesia Library
cover
Segal Abdul Aziz
Kadar procalcitonin dan perannya sebagai biomarker sepsis pada pasien tumor padat dengan metastasis jauh = Level of procalcitonin and its role as a sepsis biomarker in patient with metastatic solid tumor
"ABSTRAK
Latar Belakang: Pengaruh metastasis sebagai penyebab peningkatan procalcitonin
(PCT) pada pasien tumor padat nonsepsis masih belum jelas. Studi-studi
sebelumnya memberikan hasil yang tidak konklusif. Nilai titik potong PCT untuk
diagnosis sepsis pada tumor padat metastasis juga belum diketahui.
Tujuan: Mengetahui peran PCT dalam diagnosis sepsis pada pasien tumor padat
dengan metastasis.
Metode: Studi potong lintang terhadap pasien tumor padat yang berobat di RSCM
September-Desember 2015. Pada pasien ditentukan ada tidaknya sepsis
menggunakan kriteria sepsis ACCP/SCCM 2001, dilakukan pemeriksaan darah
perifer, serta PCT. Dilakukan analisis untuk mengetahui perbedaan kadar PCT
pasien tumor padat metastasis dan tanpa metastasis yang tidak sepsis. Selain itu,
dilakukan pula pencarian nilai titik potong PCT untuk diagnosis sepsis pada pasien
tumor padat metastasis dengan menggunakan ROC.
Hasil dan Pembahasan: Didapatkan 112 pasien tumor padat, pria sebanyak 51%,
dengan rerata usia 47,9 ±12,47 tahun. Sebanyak 71 (63,4%) pasien sudah
didapatkan metastasis, 36 (32,1%) diantaranya sepsis, dan 6 (5,3%) mengalami
SIRS. Dari 41 (36,6%) pasien tanpa metastasis, 9 (8%) mengalami sepsis, dan 5
(4,4%) SIRS. Terdapat perbedaan bermakna kadar PCT pada pasien tumor padat
metastasis dibandingkan tanpa metastasis pada kondisi nonsepsis [0,25 ng/mL
(0,07-1,76) vs. 0,09 ng/mL (0,03-0,54); p<0,001]. Pasien tumor padat metastasis
yang mengalami sepsis memiliki kadar PCT lebih tinggi dibandingkan nonsepsis
[3,5 ng/mL (0,66-189,4) vs. 0,25 ng/mL (0,07-1,76); p<0,001]. Dari kurva ROC
kadar PCT pada tumor padat metastasis, didapatkan AUC [0,956, IK 0,916-0,996]
untuk mendiagnosis sepsis. Nilai titik potong PCT untuk diagnosis sepsis pada
pasien tumor padat metastasis adalah 1,14 ng/mL dengan sensitivitas 86% dan
spesifisitas 88%.
Kesimpulan: Pada kondisi nonsepsis, kadar PCT pasien tumor padat metastasis
lebih tinggi dibandingkan pasien tanpa metastasis. Nilai titik potong PCT untuk diagnosis sepsis pada tumor padat metastasis adalah 1,14 ng/mL. ABSTRACT
Background: The effect of metastasis as a cause of increased procalcitonin (PCT)
in patients with solid tumors without sepsis remains unclear. Previous studies did
not provide conclusive results. Cut off point of PCT for sepsis diagnosis in
metastatic solid tumors is also unknown.
Objective: To determine the role of PCT in the diagnosis of sepsis toward
metastatic solid tumors patients.
Methods: A cross sectional study was conducted in solid tumor patients who were
admitted to Cipto Mangunkusumo, Jakarta between September 2015 and December
2015. The ACCP/SCCM 2001 criteria was used to identify sepsis or SIRS in
patients. Procalcitonin level, as well as routine blood examination, was performed
to determine the differences of PCT level among solid tumor patients with and
without metastasis. Cut off point of PCT for diagnosing sepsis in patients with
metastatic solid tumors was determined using ROC curve.
Results and Discussion: There were 112 patients with solid tumors, 51% male,
with mean of age 47,9 ± 12,47 years. A total of 71 (63,4%) patients had metastasis,
while 36 (32,1%) of them had sepsis and 6 (5,3%) experienced SIRS. Among 41
(36,6%) patients without metastasis, 9 (8%) had sepsis and 5 (4,4%) had SIRS. In
the absence of sepsis, the PCT level was significantly higher in patients with
metastatic solid tumors compared those without metastasis [0,25 ng/mL (0,07-1,76)
vs. 0,09 ng/mL (0,03-0,54); p<0,001]. Metastatic solid tumor patients with sepsis
had PCT levels higher than those without sepsis [3,5 ng / mL (0,66 to 189,4) vs.
0,25 ng / mL (0,07-1,76); p <0,001]. ROC curve showed that level of PCT for sepsis
in metastatic solid tumors was AUC [0,956, IK 0,916-0,996]. Cut off point of PCT
for sepsis in patients with metastatic solid tumors was 1.14 ng / mL with a
sensitivity of 86% and specificity of 88%.
Conclusion: In the absence of sepsis, PCT levels of patients with metastatic solid
tumors is higher than patients without metastasis. Cut off point of PCT for sepsis
diagnosis in metastatic solid tumors was 1,14 ng / mL. ;Background: The effect of metastasis as a cause of increased procalcitonin (PCT)
in patients with solid tumors without sepsis remains unclear. Previous studies did
not provide conclusive results. Cut off point of PCT for sepsis diagnosis in
metastatic solid tumors is also unknown.
Objective: To determine the role of PCT in the diagnosis of sepsis toward
metastatic solid tumors patients.
Methods: A cross sectional study was conducted in solid tumor patients who were
admitted to Cipto Mangunkusumo, Jakarta between September 2015 and December
2015. The ACCP/SCCM 2001 criteria was used to identify sepsis or SIRS in
patients. Procalcitonin level, as well as routine blood examination, was performed
to determine the differences of PCT level among solid tumor patients with and
without metastasis. Cut off point of PCT for diagnosing sepsis in patients with
metastatic solid tumors was determined using ROC curve.
Results and Discussion: There were 112 patients with solid tumors, 51% male,
with mean of age 47,9 ± 12,47 years. A total of 71 (63,4%) patients had metastasis,
while 36 (32,1%) of them had sepsis and 6 (5,3%) experienced SIRS. Among 41
(36,6%) patients without metastasis, 9 (8%) had sepsis and 5 (4,4%) had SIRS. In
the absence of sepsis, the PCT level was significantly higher in patients with
metastatic solid tumors compared those without metastasis [0,25 ng/mL (0,07-1,76)
vs. 0,09 ng/mL (0,03-0,54); p<0,001]. Metastatic solid tumor patients with sepsis
had PCT levels higher than those without sepsis [3,5 ng / mL (0,66 to 189,4) vs.
0,25 ng / mL (0,07-1,76); p <0,001]. ROC curve showed that level of PCT for sepsis
in metastatic solid tumors was AUC [0,956, IK 0,916-0,996]. Cut off point of PCT
for sepsis in patients with metastatic solid tumors was 1.14 ng / mL with a
sensitivity of 86% and specificity of 88%.
Conclusion: In the absence of sepsis, PCT levels of patients with metastatic solid
tumors is higher than patients without metastasis. Cut off point of PCT for sepsis
diagnosis in metastatic solid tumors was 1,14 ng / mL. ;Background: The effect of metastasis as a cause of increased procalcitonin (PCT)
in patients with solid tumors without sepsis remains unclear. Previous studies did
not provide conclusive results. Cut off point of PCT for sepsis diagnosis in
metastatic solid tumors is also unknown.
Objective: To determine the role of PCT in the diagnosis of sepsis toward
metastatic solid tumors patients.
Methods: A cross sectional study was conducted in solid tumor patients who were
admitted to Cipto Mangunkusumo, Jakarta between September 2015 and December
2015. The ACCP/SCCM 2001 criteria was used to identify sepsis or SIRS in
patients. Procalcitonin level, as well as routine blood examination, was performed
to determine the differences of PCT level among solid tumor patients with and
without metastasis. Cut off point of PCT for diagnosing sepsis in patients with
metastatic solid tumors was determined using ROC curve.
Results and Discussion: There were 112 patients with solid tumors, 51% male,
with mean of age 47,9 ± 12,47 years. A total of 71 (63,4%) patients had metastasis,
while 36 (32,1%) of them had sepsis and 6 (5,3%) experienced SIRS. Among 41
(36,6%) patients without metastasis, 9 (8%) had sepsis and 5 (4,4%) had SIRS. In
the absence of sepsis, the PCT level was significantly higher in patients with
metastatic solid tumors compared those without metastasis [0,25 ng/mL (0,07-1,76)
vs. 0,09 ng/mL (0,03-0,54); p<0,001]. Metastatic solid tumor patients with sepsis
had PCT levels higher than those without sepsis [3,5 ng / mL (0,66 to 189,4) vs.
0,25 ng / mL (0,07-1,76); p <0,001]. ROC curve showed that level of PCT for sepsis
in metastatic solid tumors was AUC [0,956, IK 0,916-0,996]. Cut off point of PCT
for sepsis in patients with metastatic solid tumors was 1.14 ng / mL with a
sensitivity of 86% and specificity of 88%.
Conclusion: In the absence of sepsis, PCT levels of patients with metastatic solid
tumors is higher than patients without metastasis. Cut off point of PCT for sepsis
diagnosis in metastatic solid tumors was 1,14 ng / mL. ;Background: The effect of metastasis as a cause of increased procalcitonin (PCT)
in patients with solid tumors without sepsis remains unclear. Previous studies did
not provide conclusive results. Cut off point of PCT for sepsis diagnosis in
metastatic solid tumors is also unknown.
Objective: To determine the role of PCT in the diagnosis of sepsis toward
metastatic solid tumors patients.
Methods: A cross sectional study was conducted in solid tumor patients who were
admitted to Cipto Mangunkusumo, Jakarta between September 2015 and December
2015. The ACCP/SCCM 2001 criteria was used to identify sepsis or SIRS in
patients. Procalcitonin level, as well as routine blood examination, was performed
to determine the differences of PCT level among solid tumor patients with and
without metastasis. Cut off point of PCT for diagnosing sepsis in patients with
metastatic solid tumors was determined using ROC curve.
Results and Discussion: There were 112 patients with solid tumors, 51% male,
with mean of age 47,9 ± 12,47 years. A total of 71 (63,4%) patients had metastasis,
while 36 (32,1%) of them had sepsis and 6 (5,3%) experienced SIRS. Among 41
(36,6%) patients without metastasis, 9 (8%) had sepsis and 5 (4,4%) had SIRS. In
the absence of sepsis, the PCT level was significantly higher in patients with
metastatic solid tumors compared those without metastasis [0,25 ng/mL (0,07-1,76)
vs. 0,09 ng/mL (0,03-0,54); p<0,001]. Metastatic solid tumor patients with sepsis
had PCT levels higher than those without sepsis [3,5 ng / mL (0,66 to 189,4) vs.
0,25 ng / mL (0,07-1,76); p <0,001]. ROC curve showed that level of PCT for sepsis
in metastatic solid tumors was AUC [0,956, IK 0,916-0,996]. Cut off point of PCT
for sepsis in patients with metastatic solid tumors was 1.14 ng / mL with a
sensitivity of 86% and specificity of 88%.
Conclusion: In the absence of sepsis, PCT levels of patients with metastatic solid
tumors is higher than patients without metastasis. Cut off point of PCT for sepsis
diagnosis in metastatic solid tumors was 1,14 ng / mL. ;Background: The effect of metastasis as a cause of increased procalcitonin (PCT)
in patients with solid tumors without sepsis remains unclear. Previous studies did
not provide conclusive results. Cut off point of PCT for sepsis diagnosis in
metastatic solid tumors is also unknown.
Objective: To determine the role of PCT in the diagnosis of sepsis toward
metastatic solid tumors patients.
Methods: A cross sectional study was conducted in solid tumor patients who were
admitted to Cipto Mangunkusumo, Jakarta between September 2015 and December
2015. The ACCP/SCCM 2001 criteria was used to identify sepsis or SIRS in
patients. Procalcitonin level, as well as routine blood examination, was performed
to determine the differences of PCT level among solid tumor patients with and
without metastasis. Cut off point of PCT for diagnosing sepsis in patients with
metastatic solid tumors was determined using ROC curve.
Results and Discussion: There were 112 patients with solid tumors, 51% male,
with mean of age 47,9 ± 12,47 years. A total of 71 (63,4%) patients had metastasis,
while 36 (32,1%) of them had sepsis and 6 (5,3%) experienced SIRS. Among 41
(36,6%) patients without metastasis, 9 (8%) had sepsis and 5 (4,4%) had SIRS. In
the absence of sepsis, the PCT level was significantly higher in patients with
metastatic solid tumors compared those without metastasis [0,25 ng/mL (0,07-1,76)
vs. 0,09 ng/mL (0,03-0,54); p<0,001]. Metastatic solid tumor patients with sepsis
had PCT levels higher than those without sepsis [3,5 ng / mL (0,66 to 189,4) vs.
0,25 ng / mL (0,07-1,76); p <0,001]. ROC curve showed that level of PCT for sepsis
in metastatic solid tumors was AUC [0,956, IK 0,916-0,996]. Cut off point of PCT
for sepsis in patients with metastatic solid tumors was 1.14 ng / mL with a
sensitivity of 86% and specificity of 88%.
Conclusion: In the absence of sepsis, PCT levels of patients with metastatic solid
tumors is higher than patients without metastasis. Cut off point of PCT for sepsis
diagnosis in metastatic solid tumors was 1,14 ng / mL. "
Fakultas Kedokteran Universitas Indonesia, 2016
SP-PDF
UI - Tugas Akhir  Universitas Indonesia Library
cover
Reza Nugraha Yulisar
Kadar Procalcitonin sebagai Biomarker Sepsis pada Pasien Tumor Padat dengan Demam dan Leukositosis = Cut-off Level of Serum Procalcitonin for Sepsis Diagnosis in Advanced Solid Tumor Patients with Fever and Leucocytosis
"Latar Belakang: Diagnosis sepsis pada pasien tumor padat metastasis sulit karena adanya gejala, seperti demam dan leukositosis, dapat timbul tanpa adanya infeksi. Procalcitonin (PCT) merupakan salah satu parameter untuk mendiagnosis sepsis. Titik potong PCT untuk diagnosis sepsis pada pasien tumor padat metastasis dengan demam dan leukositosis masih belum diketahui. Studi sebelumnya belum ada yang menilai titik potong PCT pada pasien tumor padat metastasis dengan demam dan leukositosis.
Tujuan: Mengetahui titik potong PCT dalam diagnosis sepsis pada pasien tumor padat metastasis dengan demam dan leukositosis.
Metode: Studi potong lintang terhadap pasien tumor padat metastasis dengan demam dan leukositosis yang berobat di RSCM Juni 2016 - April 2018. Pada pasien ditentukan ada tidaknya sepsis menggunakan kriteria sepsis sesuai The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3), yaitu menggunakan mSOFA. Dilakukan pemeriksaan darah perifer dan PCT. Dilakukan pencarian nilai titik potong PCT untuk diagnosis sepsis pada pasien tumor padat metastasis dengan demam dan leukositosios menggunakan ROC.
Hasil: Didapatkan 86 pasien tumor padat metastasis dengan demam dan lekositosis, dengan wanita sebanyak 61,6%, rerata usia 49,48 ±11,44 tahun. Sebanyak  43 pasien (50%) mengalami sepsis. Dari kurva ROC kadar PCT pada tumor padat metastasis dengan demam dan leukositosis yang mengalami sepsis, didapatkan AUC [0,873 ,IK 0,799 - 0,946, p <0,001]. Nilai titik potong PCT untuk diagnosis sepsis pada pasien tumor padat metastasis dengan demam dan leukositosis adalah 1,755 ng/mL dengan sensitivitas 76,7% dan spesifisitas 81,4%, NDP 80,5%, NDN 77,8%.
Kesimpulan: Nilai titik potong PCT untuk diagnosis sepsis pada tumor padat metastasis dengan demam dan leukositosis adalah 1,755 ng/mL.
Background: Diagnosis of infection in advanced solid tumor patients can be difficult since fever and leucocytosis is a non-specific clinical marker and can occur without infections. Untreated infections can lead to sepsis, increasing mortality in those patients. Procalcitonin has been used to support the diagnosis of sepsis. Procalcitonin cut off in advanced stage solid tumor patients with fever as a sepsis biomarker is still unclear. No study has seen procalcitonin cut-off in advanced solid tumor patients with fever.
Objective: To discover the cut-off point for sepsis in advanced solid tumor patients with fever.
Method: A cross-sectional study was conducted in the advanced solid tumor patients with fever patients who were admitted to Cipto Mangunkusumo Hospitals, Indonesia during June 2016 to April 2018. Demographic characteristics, physical examinations, laboratory examinations were recorded. Sepsis was defined using 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference criteria.
Results: A total of 86 subjects were enrolled in this study, 61,6% were female with mean age 49,5 years old. Among them, 43 patients (50%) were diagnosed with sepsis. The ROC curve showed that the levels of procalcitonin for sepsis in advanced solid tumor patients with fever was in the area under curve (AUC) 0,891 (CI 826 - 956). Cut-off procalcitonin for diagnosing sepsis in advanced solid tumor patients with fever was 1,755 ng/mL, sensitivity 76,7%, specificity 81,4%, PPV 80,5%, NPV 77,8%.
Conclusions: The cut-off point of procalcitonin level to support sepsis diagnosis in advanced solid tumor patients with fever was higher than normal populations."
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2018
T58575
UI - Tesis Membership  Universitas Indonesia Library
cover
Hari Sandi Sumardi Wiranegara
Analisis aktivitas superoxide dismutase dan malindaldehyde pada penderita keganasan ovarium dan tumor jinak ovarium = Analysis of activity of superoxide dismutase and malondialdehyde in patients with ovarian malignancy and ovarian benign tumors
"Kanker ovarium masih menempati urutan kedua terbanyak dalam keganasan ginekologi dan merupakan penyebab utama kematian akibat kanker pada perempuan. Banyak bukti menunjukkan bahwa kanker ovarium umunya dalam pengaruh stress oksidatif. Dalam penelitian ini bertujuan untuk mengetahui aktivitas stress oksidatif melalui pengukuran enzim Superoxide Dismutase (SOD) dan kadar Malondialdehyde (MDA) pada penderita keganasan ovarium dibandingkan dengan penderita tumor jinak ovarium. Penelitian dilakukan dengan uji potong-lintang yang dilaksanalan di Ruang Rawat Kebidanan Ginekologi RSCM Jakarta, RS Persahabatan Jakarta dan RS Fatmawati Jakarta pada Juli hingga Desember 2018. Seluruh penderita keganasan ovarium dan penderita tumor jinak ovarium yang memenuhi kriteria diikutsertakan dalam penelitian ini. Darah penderita tumor ovarium diambil sebelum dilakukan operasi, lalu sampel dilakukan pengukuran kadar SOD dan MDA. Terdapat 35 penderita keganasan ovarium dan 43 penderita tumor jinak ovarium yang diikutsertakan dalam penelitian ini. Rerata atau median kadar SOD dan MDA pada penderita keganasan ovarium adalah 1,23 (0,24-5,709) dan 0,803 ± 0,316 , sementara rerata atau median kadar SOD dan MDA pada penderita tumor jinak ovarium adalah 0,488 (0,101-1,86) dan 0,634 ± 0,266. Terdapat perbedaan kadar SOD dan MDA yang bermakna antara kedua kelompok. Terdapat perbedaan kadar SOD yang bermakna antara penderita keganasan ovarium stadium awal dengan penderita keganasan ovarium stadium lanjut. Sementara pada pemeriksaan MDA tidak terdapat perbedaan bermakna antara penderita stadium awal dengan stadium lanjut. Kesimpullan pada penelitian ini terdapat perbedaan kadar SOD dan MDA yang bermakna antara penderita keganasan ovarium dengan penderita tumor jinak ovarium.
Ovarian cancer is the leading cause of death due to gynecological malignancies among women. A lot of evidence shows that ovarian cancer is generally influenced by oxidative stress. In this study aims to determine the activity of SOD enzymes and MDA levels in patients with ovarian malignancies and patients with benign ovarian tumors. The study was conducted by cross-sectional tests carried out in the RSCM Jakarta Gynecology Obstetric Room and Persahabatan Hospital Jakarta and Fatmawati Hospital Jakarta in July to December 2018. All patients with ovarian malignancies and patients with benign ovarian tumors who met the criteria were included in this study. Blood from ovarian tumor patients taken before surgery, then the samples were measured for SOD and MDA levels. There were 35 ovarian malignancies and 43 patients with benign ovarian tumors included in the study. The mean or median level of SOD and MDA in patients with ovarian malignancy is 1.23 (0.24 - 5.709) and 0.803 ± 0.316, while the mean or median level of SOD and MDA in patients with benign ovarian tumors is 0.488 (0.101-1.86) and 0.634 ± 0.266. There were significant differences in SOD and MDA levels between the two groups. There were significant differences in SOD levels between patients with early-stage ovarian malignancies and those with advanced ovarian malignancies. While on MDA examination there were no significant differences between patients with early stages with advanced stages. Conclusion in this study were significant differences in SOD and MDA levels between ovarian malignancies and patients with benign ovarian tumors"
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2019
SP-pdf
UI - Tugas Akhir  Universitas Indonesia Library
cover
Annisa Prasetyo Ningrum
Akurasi diagnostik: sensitivitas dan spesifisitas pada subskala kecemasan hopkins symptom check list-25 (HSCL-25) sebagai alat skrining kecemasan pada remaja = Diagnostic accuracy: sensitivity and specificity of hopkins symptom check list - 25 (HSCL-25) anxiety subscale as an anxiety screening tool in adolescents
"Latar Belakang: Penelitian ini merupakan bagian dari penelitian jangka panjang mengenai kesehatan mental remaja. Studi pedahuluan dari penelitian ini menemukan fakta bahwa masalah gejala kecemasan menduduki peringkat pertama prevalensi 84.9 , berdasarkan hasil tes skrining menggunakan subskala kecemasan Hopkins Symptom Check List ndash; 25 HSCL-25.
Tujuan: Untuk mengetahui sensitivitas dan spesifisitas pada subskala kecemasan HSCL-25 dalam mengidentifikasi kecemasan jika dibandingkan dengan gold standard berupa wawancara diagnostik, serta mengidentifikasi nilai cut-off yang tepat dalam penggunaan subskala kecemasan HSCL-25 pada populasi remaja.
Metode: Membandingkan kecenderungan kecemasan berdasarkan hasil skrining HSCL-25 dengan hasil wawancara diagnostik menggunakan modul skrining Structured Clinical Interview for DSM-IV SCID sebagai acuan pembuatan gold standard. Proses penelitian menggunakan teknik double-blind dengan bantuan tim penelitian. Wawancara dilakukan kepada 40 orang remaja siswa SMA di wilayah DKI Jakarta, mengacu pada hasil skrining.
Hasil: Subskala kecemasan HSCL-25 memiliki nilai sensitivitas sebesar 0.50 dan nilai spesifisitas sebesar 0.50. Skor cut-off HSCL-25 sebesar 1.75 yang digunakan dalam penelitian ini kurang ideal dalam mengidentifikasi individu dengan masalah kecemasan pada populasi remaja.
Kesimpulan: Subskala kecemasan HSCL-25 memiliki kemampuan terbatas dalam mengidentifikasi kecemasan yang mengarah pada gangguan pada populasi remaja. Oleh sebab itu, HSCL-25 tidak disarankan sebagai alat skrining tunggal dalam mengukur kecenderungan gangguan kecemasan pada populasi ini. Terdapat pula kemungkinan bahwa gold standard yang dipilih dalam penelitian ini kurang sesuai sebagai pembanding HSCL-25. Penelitian selanjutnya diharapkan dapat mempersingkat interval waktu antara proses skrining dan wawancara, serta mempertimbangkan pemilihan gold standard yang lebih sesuai.
Background: This study is part of a longitudinal study about adolescent's mental health. A preliminary study of this study found that anxiety symptoms were ranked first prevalence 84.9, based on screening using Hopkins Symptom Check List 25 HSCL 25 anxiety subscale.
Objective: To determine the sensitivity and specificity of the HSCL 25 anxiety subscale compared to the diagnostic interview as a gold standard, as well as identifying appropriate cut off score for HSCL 25 anxiety subscale in adolescent's population.
Methods: Comparing HSCL 25 anxiety score with the results of diagnostic interview using the Structured Clinical Interview for DSM IV SCID screening module as the gold standard. This study was conducted using double blind technique, and the blinding process was assisted by the research team. Interviews were conducted to 40 high school students in DKI Jakarta, based on screening results.
Results: Anxiety subscale of HSCL 25 has a 0.50 sensitivity and 0.50 specificity. The cut off score used in this study 1.75 is less than ideal in identifying individuals with anxiety problems in adolescent populations.
Conclusion: The anxiety subscale of HSCL 25 has limited ability to identify anxiety disorder in adolescent populations. Therefore, it is not recommended as a single screening tool in measuring the anxiety disorder trends in this population. It is also possible that the gold standard chosen in this study is less suitable as a comparison of HSCL 25. Further research is expected to shorten the time interval between the screening process and interviews, as well as consider more appropriate gold standard selection."
Depok: Fakultas Psikologi Universitas Indonesia, 2018
T49188
UI - Tesis Membership  Universitas Indonesia Library
<<   1 2 3 4 5 6 7 8 9 10   >>